TRIB: מחיר חזוי לרווח trinitybiotech.com
The forward P/E ratio dynamics reflect the current growth trajectory of Trinity Biotech plc (TRIB), which relies on external logistics for test delivery. Growth is driven by distributor partnerships and the acquisition of IT solutions for diabetics. Global sales of consumables for HIV and infection diagnostics provide a stable revenue stream. The 0.00 indicator captures the value of this parameter on the chart.
פילוחים אנליטיים ודוחות נתונים של חברת Trinity Biotech Corp (TRIB)
The forward P/E reflects the market value of Trinity Biotech plc (TRIB) relative to projected earnings per share, allowing for an assessment of the asset's fair value based on expected cash flows. By analyzing the company's forward P/E history, an investor can compare the growth rates of rapid hemoglobin diagnostics with market expectations to determine whether they are overpaying for the issuer's dominance in the portable analyzer niche.
